NEPHROHUB • ADVANCED INTERACTIVE CASE
Educational disclaimer: This postgraduate case is for education and does not replace bedside assessment, local protocols, senior nephrology input, current prescribing information, or patient-specific evaluation.
Difficulty and format
Difficulty: Advanced. Format: Four-stage branching emergency and follow-up case focused on diagnosis, protocol-based intraperitoneal antibiotics, culture-directed treatment, catheter-removal decisions, and prevention.
Learning objectives
By the end of this case, learners should be able to apply the ISPD diagnostic definition, distinguish infectious from noninfectious cloudy effluent, start empiric therapy promptly after appropriate specimens, individualize intraperitoneal antibiotic dosing, recognize response and treatment failure, identify catheter-removal indications, and build a prevention and retraining plan.
Stage 1 — Recognize and diagnose PD-associated peritonitis
Presentation
Mr. David Kim is a 45-year-old accountant with kidney failure from polycystic kidney disease. He has used continuous ambulatory peritoneal dialysis for 14 months with four exchanges daily. He presents with 24 hours of abdominal discomfort and cloudy drained effluent. Temperature is 38.2°C, heart rate 95/min, blood pressure 145/88 mmHg, and he has diffuse mild abdominal tenderness without rebound or guarding. The catheter exit site and tunnel are clean and nontender.
Decision point 1 — Initial approach
Preferred decision: Treat cloudy effluent as peritonitis until excluded. Obtain a peritoneal-effluent cell count and differential, Gram stain, and bacterial culture promptly, while assessing for sepsis, catheter-related infection, and non-PD intra-abdominal emergencies. Consider blood cultures because he has fever and systemic inflammatory features. Do not delay empiric therapy once appropriate specimens have been collected.
The ISPD diagnosis generally requires at least two of three findings: compatible clinical features such as abdominal pain or cloudy effluent; effluent white-cell count greater than 100/µL after an adequate dwell, with more than 50% polymorphonuclear cells; and a positive effluent culture. Gram stain may be negative. Cloudy effluent alone does not prove infection; fibrin, blood, chyle, eosinophilic or chemical peritonitis, and non-PD abdominal pathology remain considerations.
Stage 2 — Start protocol-based empiric therapy
Peritoneal-fluid results
The effluent is turbid. Cell count is 850 WBC/µL with 85% neutrophils. Gram stain shows numerous leukocytes but no organisms. Cultures are sent using the dialysis unit’s validated processing method. The exit site remains clean, and there is no peritoneal-dialysis catheter tunnel tenderness.
Decision point 2 — Empiric antibiotics
Preferred decision: After specimens are obtained, start prompt empiric antibiotics with intraperitoneal administration when feasible, covering both Gram-positive and Gram-negative organisms, including Pseudomonas according to local microbiology and protocol. Vancomycin plus ceftazidime is one possible framework, but the precise dose, intermittent or continuous method, dwell requirements, and monitoring must be individualized to CAPD/APD prescription, residual kidney function, local resistance patterns, allergies, and drug levels where applicable.
Antibiotics should be added to dialysis solution and dwelled according to the PD unit’s compatibility and administration protocol. Short APD dwells may require specific adjustments. Add antifungal prophylaxis during the antibiotic course according to local policy and patient factors, commonly oral nystatin or fluconazole after checking interactions and contraindications.
Stage 3 — Interpret cultures and assess response
Culture result
After 48 hours, culture grows methicillin-resistant coagulase-negative Staphylococcus epidermidis, susceptible to vancomycin. No Gram-negative organism is isolated. The patient’s abdominal pain improves and the effluent begins to clear by day 3.
Decision point 3 — Targeted treatment and response
Preferred decision: Stop unnecessary Gram-negative therapy and continue protocol-based vancomycin with monitoring and dose adjustment. For uncomplicated coagulase-negative staphylococcal peritonitis with prompt clinical response, approximately two weeks of effective therapy is commonly recommended; the final duration should follow the current ISPD/local protocol, organism, catheter status, and response.
Monitor symptoms, temperature, hemodynamics, effluent clarity, catheter function, exit site and tunnel, drug toxicity, and serial effluent WBC/PMN trends when clinically indicated. A falling day-3 cell count is reassuring but does not by itself define cure. Refractory disease should be considered when effluent fails to clear after about five days of appropriate therapy, while a steadily falling cell count may support carefully monitored continuation in selected cases.
Escalation branch — When to remove the catheter
Consider catheter removal and temporary hemodialysis planning for refractory, relapsing, recurrent, fungal, mycobacterial, or selected catheter-related peritonitis, particularly when there is poor clinical response or a persistent infected biofilm. Reassess for intra-abdominal pathology and seek surgical/infectious-disease input when the course is atypical, severe, or nonresponsive. Catheter removal is not required merely because Gram stain is negative or because the day-3 count has not normalized.
Stage 4 — Prevent recurrence and strengthen the PD system
Prevention review
The patient recovers with clearing effluent and resolution of pain. The dialysis nurse performs structured technique reassessment rather than accepting historical compliance as proof that no risk factor exists.
Decision point 4 — Prevention plan
Preferred decision: Build an individualized prevention bundle: observe and retrain exchange technique; reinforce hand hygiene and a clean exchange environment; review exit-site care and topical antibiotic prophylaxis according to local policy; establish a contamination-management plan; assess for exit-site or tunnel infection; review modifiable risks such as barriers to training, pets, hypokalaemia, acid-suppression exposure, and medication complexity; and provide clear instructions to contact the PD team immediately for cloudy effluent, abdominal pain, fever, or drainage.
Review local recommendations for antibiotic prophylaxis before selected invasive procedures, and reassess technique after any peritonitis or contamination event. The goal is not only successful treatment of this episode but also prevention of recurrence, preservation of the peritoneal membrane, and safe continuation of the patient’s preferred dialysis modality.
Expert synthesis
PD-associated peritonitis is a time-sensitive diagnosis and management problem. Cloudy effluent should trigger immediate testing and treatment while the team considers infectious and noninfectious causes. Diagnosis uses a two-of-three framework combining symptoms or cloudy effluent, an inflammatory effluent cell profile, and culture. Empiric intraperitoneal therapy should cover Gram-positive and Gram-negative organisms according to local protocols; dosing and dwell depend on the PD prescription. Once cultures return, narrow therapy and choose duration according to the organism and response. Refractory, relapsing, recurrent, fungal, mycobacterial, and selected catheter-related infections require early multidisciplinary escalation. Prevention depends on training quality, retraining, exit-site care, contamination protocols, and rapid patient contact when symptoms recur.
Advanced Self-Assessment
Complete the accompanying ten-question Advanced assessment. Detailed explanations are provided after submission.
References
- Li PK-T, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.
- International Society for Peritoneal Dialysis guidelines and educational resources.
- ISPD 2022 guideline full text.
NephroHub — postgraduate clinical education in nephrology.